Titre : | The abuse liability of dextromethorphan among adolescents: a review (2005) |
Titre traduit : | (L'abus de dextrométhorphane chez des adolescents : une revue de la littérature) |
Auteurs : | BOBO W. V. ; S. C. MILLER ; B. D. MARTIN |
Type de document : | Article : Périodique |
Dans : | Journal of Child and Adolescent Substance Abuse (Vol.14, n°4, 2005) |
Article en page(s) : | 55-75 |
Langues: | Anglais |
Discipline : | EPI (Epidémiologie / Epidemiology) |
Mots-clés : |
Thésaurus mots-clés ADOLESCENT ; ABUS ; ANTITUSSIFS ; MESUSAGE ; MEDICAMENTS ; SURVEILLANCE EPIDEMIOLOGIQUE |
Résumé : | Dextromethorphan (DM) is a popular over-the-counter antitussive medication. Although adverse effects from appropriate use are rare, a specific toxidrome with significant psychomimetic effects occurs with ingestions in excess of those recommended. Both DM and its active metabolite, dextrorphan (DOR), share pharmacologic and neurobehavioral properties similar to opiates and phencyclidine (PCP). As such, cases of recreational DM abuse and, rarely, dependence have been reported, and some data suggest that such abuse is on the rise. DM may be considered by substance abusers, especially adolescents, to be a dissociative agent devoid of financial concerns, legal limitations, negative stigma, problems with access or adverse health consequences. However, DM's popularity among adolescent substance abusers is generally not matched by adequate health care provider awareness, pharmacological understanding or epidemiological characterization. In this review, we summarize the current understanding of DM's addiction medicinebased neuropharmacology and epidemiology, describe social characteristics more unique to DM as an agent of abuse, review treatment and prevention issues, and identify areas in need of further research. (Editor's abstract.) |
Domaine : | Autres substances / Other substances |
Sous-type de document : | Revue de la littérature / Literature review |
Refs biblio. : | 108 |
Affiliation : | Uniformed Services University of the Health Sciences Bethesda, MD and Staff Psychiatrist, Naval Hospital, Jacksonville, FL, USA |
Numéro Toxibase : | 404976 |
Centre Emetteur : | 04 CIRDD-51 |
Cote : | Abonnement |
Accueil